The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators. As Bloomberg Law reported last week, the FDA has withdrawn the proposed rule, “Reporting Information Regarding Falsification of Data,” which would
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a call for more than 30 retractions by former Harvard … Continue reading Weekend reads: A whistleblower speaks; a new most-cited retracted paper; criminalizing scientific fraud?
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. This week at Retraction Watch featured the retraction of happiness, an apology from a journal, and … Continue reading Weekend reads: An article on a controversial topic just disappears; mass resignations from a nutrition journal; the likely mistaken history of the vibrator
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a look at a court case that suggests senior researchers … Continue reading Weekend reads: Researcher loses grant following bullying allegations; 40+ retractions later, still an enigma; predatory journal critic suspended
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured the departure of a professor in Glasgow amidst three retraction; … Continue reading Weekend reads: Why rhetoric and self-censorship is bad for science; an author threatens to sue his critics; why whistleblowing is critical
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured, unfortunately, a likely DDOS attack that kept our site dark … Continue reading Weekend reads: “Chronic compulsive writing syndrome;” a new way to respond to rejection; rewards for a center that doesn’t yet exist
A journal has temporarily removed a study by a researcher who has long championed a highly controversial “abortion reversal” method over concerns about its ethical approval. The study, “A Case Series Detailing the Successful Reversal of the Effects of Mifepristone Using Progesterone,” appeared in Issues In Law And Medicine in April. Its first author, George … Continue reading Study claiming “abortion reversal” is safe and effective temporarily withdrawn for ethical issues
As many readers know, even after a paper’s retracted, it will continue to be cited — often by researchers who don’t realize the findings are problematic. But when, and in what context, do those citations occur? In a recent paper in Scientometrics, Judit Bar-Ilan of Bar-Ilan University in Israel and Gali Halevi at Icahn School … Continue reading Retracted papers keep being cited as if they weren’t retracted. Two researchers suggest how Elsevier could help fix that.
Over the years, we have written about a number of the sleuths who, on their own time and often at great risks to their careers or finances, have looked for issues in the scientific literature. Here’s a sampling:
The president of the Karolinska Institutet (KI) is frustrated. At the beginning of the year, Ole Petter Ottersen informed a journal that one of its papers — co-authored by former superstar Paolo Macchiarini — had been tainted by misconduct. But the journal declined to retract it. Despite the fact that KI had conducted its own … Continue reading Karolinska told a journal to retract a paper by Macchiarini. It refused. The story didn’t end there.